Decentralized Clinical Trials
Decentralized trials promise flexibility and speed—but delivering it without compromising safety, data quality, or site workflows is a real challenge.
Medidata’s integrated Decentralized Clinical Trials (DCT) program helps teams run hybrid and fully remote trials that work for patients, sites, and sponsors alike—using Medidata Consent, eCOA, and Sensors solutions designed for real-world execution.
Run Your DCT
from
One Platform
Decentralized trials place new demands on patients and sites. From unfamiliar technology to coordinating drug delivery and lab collection, teams must still maintain compliance and data quality.
You need a solution that supports it all, simply and in one place.
Suite of Patient Engagement Solutions
Continuous Clinical Data Monitoring
Direct-to-patient (DtP) Investigational Product Delivery
Circuit Clinical Partnership for Turnkey Solution
Flexible, Custom Design with Medidata’s Trial Dial™
Built to Ease Complexity for Everyone
Sponsors
For Sponsors:
Control and Confidence
Centralized oversight helps sponsors maintain compliance, data integrity, and patient safety—while scaling decentralized, hybrid, or fully remote trials with confidence.
Download Fact Sheet
Explore the Solutions
Patient Engagement
Engage, consent, and collect outcomes from patients wherever they are—improving recruitment, retention, and data quality.
Explore the Patient Experience
Digital Oversight
Maintain data quality and operational control with remote, risk-based monitoring and real-time trial insights.
Explore the Study Experience
Direct-to-patient Shipping
See how changes to enrollment, timelines, or protocols affect cost over time.
Explore RTSM
FAQ
Can Medidata’s DCT solution support hybrid trial designs?
Yes. The program is designed to be scalable and flexible, allowing you to virtualize as much or as little of a clinical trial as needed. It supports a hybrid approach through unified technologies like Medidata eConsent, eCOA, and Sensors solutions, ensuring high-quality data collection regardless of geography or trial complexity.
Does Medidata offer access to a network of DCT-ready sites?
Yes. Through a partnership with Circuit Clinical, Medidata provides a turnkey solution that includes a national network of decentralized sites. These sites are already trained and certified on Medidata technology, which enhances patient access and inclusion while ensuring standardization across the study.
How does the platform handle direct-to-patient (DtP) supply management?
Medidata RTSM features robust DtP capabilities that offer high flexibility for decentralized and hybrid trials. It allows shipments to be triggered at the site, visit, or patient level, and enables patients to confirm incoming shipments directly through their myMedidata account.
How does the solution ensure data quality with remote monitoring?
Medidata addresses data quality challenges in DCTs through centralized, remote, and risk-based monitoring (RBQM) capabilities built on a unified platform. This allows study teams to shift from 100% on-site monitoring to remote oversight activities without sacrificing timelines or data integrity.
Does Medidata offer training for its clients and partners?
Yes. Medidata offers a variety of training options for our clients and partners, including both self-paced and instructor-led courses. To learn more about available courses and to access our resources, please visit the Medidata Global Education and Training section.